Decreased serum melatonin levels in rats with experimental autoimmune uveitis/pinealitis and in patients with uveitis.

The authors measured serum levels of the pineal hormone melatonin to investigate the possibility of pineal dysfunction in both rats with experimental autoimmune uveitis/pinealitis (EAU/EAP) and uveitis patients. The serum melatonin concentrations of EAU/EAP rats were measured by radioimmunoassay over a 24-hour (h) period, and in uveitis patients at night (0200 h). Melatonin concentrations were assayed in six patients with Behçet's disease, four with Vogt-Koyanagi-Harada (VKH) disease, three with sarcoidosis, three with Kirisawa-type uveitis, and one with tubulointerstitial nephritis and uveitis syndrome. Nocturnal serum melatonin levels were significantly lower in Lewis rats with EAU/EAP (2200 h: 33.6±20.4 pg/ml, 0200 h: 43.2±13.9 pg/ml) than in the controls (2200 h: 117.5±25.3 pg/ml, 0200 h: 132.4±20.2 pg/ml) (p>0.01, at 2200 h and 0200 h). Melatonin levels were significantly lower in VKH disease (20.7±10.5 pg/ml) (p>0.01) and Behçet's disease (42.1±42.5 pg/ml) (p>0.05) than in the controls (79.4±36.7 pg/ml). These results suggest that there is a decrease in pineal gland function due to pinealitis in EAU/EAP rats. The markedly decreased nocturnal serum melatonin levels may also be related to the presence of retinal uveitogenic antigens in uveitis patients.